Form 4 Tracker
HALOZYME THERAPEUTICS, INC.
HALO

32 insider filings · Latest: Jul 1, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Sep 26, 2024Sep 26 8:05 PMHELEN TORLEY
Proposed Sale
10,000$56.10$561.0K

View →

Sep 25, 2024Sep 25 8:00 PMHELEN TORLEY
Proposed Sale
10,000$56.34$563.4K

View →

Sep 24, 2024Sep 24 8:05 PMHELEN TORLEY
Proposed Sale
10,000$58.21$582.1K

View →

Sep 18, 2024Sep 18 8:01 PMMICHAEL LABARRE
Proposed Sale
10,000$62.03$620.3K

View →

Sep 17, 2024Sep 17 8:03 PMMICHAEL LABARRE
Proposed Sale
10,000$62.88$628.8K

View →

Sep 12, 2024Sep 12 8:12 PMHELEN TORLEY
Proposed Sale
10,000$59.20$592.0K

View →

Sep 11, 2024Sep 11 8:05 PMHELEN TORLEY
Proposed Sale
10,000$59.09$590.9K

View →

Sep 10, 2024Sep 10 8:16 PMHELEN TORLEY
Proposed Sale
10,000$59.09$590.9K

View →

← Previous

Page 3 of 3

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Feb 5, 2026Feb 6 12:38 AMHelen TorleyDirector, PRESIDENT AND CEO
Option Exercise
10,000$12.07201,923(D)

View →

Feb 4, 2026Feb 6 12:38 AMHelen TorleyDirector, PRESIDENT AND CEO
Option Exercise
20,000$12.07211,923(D)

View →

Feb 3, 2026Feb 6 12:38 AMHelen TorleyDirector, PRESIDENT AND CEO
Option Exercise
20,000$12.07231,923(D)

View →

← Previous

Page 3 of 3